Another upbeat update from Avingtrans which follows from its recent profit upgrade (click here). The key themes will be familiar to Avingtrans’ watchers: a core Engineering business which is going from strength to strength and outperforming expectations, whilst Medical is still early in its corporate journey but making progress towards key milestones. AVG should be a core holding in our view on account of strategic execution and exposure to enduring growth trends. TP rises from 525p to 580p, dri ....
